Koninklijke Philips N.V. (PHG) P/E Ratio History
Historical price-to-earnings valuation from 2001 to 2025
Loading P/E history...
PHG Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 6, 2026, Koninklijke Philips N.V. (PHG) trades at a price-to-earnings ratio of 24.9x, with a stock price of $27.23 and trailing twelve-month earnings per share of $0.93.
The current P/E is 41% below its 5-year average of 42.5x. Over the past five years, PHG's P/E has ranged from a low of 7.0x to a high of 170.4x, placing the current valuation at the 25th percentile of its historical range.
Compared to the Healthcare sector median P/E of 22.1x, PHG is roughly in line with its sector peers. The sector includes 242 companies with P/E ratios ranging from 0.0x to 178.0x.
Relative to the broader market, PHG trades roughly in line with the S&P 500 median P/E of 25.2x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our PHG DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
PHG P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $112B | 34.8 | 2.34 | +8% | |
| $83B | 28.9 | - | +55%Best | |
| $48B | 45.5 | 6.42 | -74% | |
| $16B | 23.3 | - | -20% | |
| $99B | 21.5 | - | +31% | |
| $320B | 37.5 | 3.17 | +36% | |
| $28B | 13.6Lowest | - | +5% | |
| $2B | 15.9 | 0.91Best | +45% | |
| $160B | 57.4 | 2.64 | +23% |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
PHG Historical P/E Data (2001–2025)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2025 Q4 | Wed Dec 31 2025 00:00:00 GM | $27.08 | $0.93 | 29.1x | -20% |
| FY2025 Q3 | $27.26 | $0.16 | 170.4x | +370% | |
| FY2025 Q2 | Mon Jun 30 2025 00:00:00 GM | $23.98 | $0.17 | 141.1x | +289% |
| FY2025 Q1 | Mon Mar 31 2025 00:00:00 GM | $25.40 | $0.40 | 63.5x | +75% |
| FY2022 Q2 | $21.53 | $3.09 | 7.0x | -81% | |
| FY2022 Q1 | $28.26 | $3.27 | 8.6x | -76% | |
| FY2021 Q4 | Fri Dec 31 2021 00:00:00 GM | $34.11 | $3.47 | 9.8x | -73% |
| FY2021 Q3 | $41.13 | $3.93 | 10.5x | -71% | |
| FY2021 Q2 | Wed Jun 30 2021 00:00:00 GM | $46.00 | $1.18 | 39.0x | +8% |
| FY2021 Q1 | Wed Mar 31 2021 00:00:00 GM | $52.79 | $1.24 | 42.6x | +18% |
| FY2020 Q4 | $50.14 | $1.24 | 40.4x | +12% | |
| FY2020 Q3 | Wed Sep 30 2020 00:00:00 GM | $43.64 | $1.19 | 36.7x | +1% |
Average P/E for displayed period: 36.2x
Full PHG Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
See PHG's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs PHG Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare PHG vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonPHG — Frequently Asked Questions
Quick answers to the most common questions about buying PHG stock.
Is PHG stock overvalued or undervalued?
PHG trades at 24.9x P/E, below its 5-year average of 42.5x. At the 25th percentile of historical range, the stock is priced at a discount to its own history.
How does PHG's valuation compare to peers?
Koninklijke Philips N.V. P/E of 24.9x compares to sector median of 22.1x. The premium reflects expected growth above peers.
What is PHG's PEG ratio?
PHG PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2001-2025.